April 12, 2016: Here are four stocks trading with relatively heavy volume among 17 equities making new 52-week lows in Tuesday’s session. The day’s NYSE winners led losers by about 3 to 1. Nasdaq winners outpaced losers by about 3 to 2.
Och-Ziff Capital Management Group LLC (NYSE: OZM) posted a new 52-week low on Tuesday. Shares traded at a low of $2.89, down about 24%, after closing at $3.80 on Monday. The stock’s 52-week high is $13.49. Volume totaled more than 8 times the daily average of around 1.2 million shares. Federal prosecutors apparently want the hedge fund to plead guilty and pay a $400 million fine to resolve allegations that the company violated the Foreign Corrupt Practices Act in deals with African nations.
Allergan plc (NYSE: AGN) dropped about 3.3% on Tuesday to post a new 52-week low of $220.75 against a 52-week high of $340.34. The stock closed at $228.37 on Monday night. Volume was about double the stock’s daily average volume of around 4.2 million. The giant pharmaceutical house had no specific news Tuesday.
Endo International plc (NASDAQ: ENDP) fell by about 3.1% on Tuesday to post a new 52-week low of $25.23 against a high of $96.58. The stock closed at $26.03 on Monday night. Volume totaled about 8 million shares, more than 20% above the daily average of about 6.4 million. Another drugmaker’s stock posting a new low with no specific news.
Clovis Oncology Inc. (NASDAQ: CLVS) dropped about 18.7% on Tuesday to post a new 52-week low at $12.25 after closing at $15.06 on Monday. The stock’s 52-week high is $116.75. Share volume of around 3.6 million was nearly 3 times the daily average of about 1.3 million shares traded. An FDA panel has recommended against approval for the company’s proposed lung cancer drug based on the existing trial data.
Find a Qualified Financial Advisor (Sponsor)
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.